NO20062506L - Tissue-protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues, and organs with an extended therapeutic window - Google Patents

Tissue-protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues, and organs with an extended therapeutic window

Info

Publication number
NO20062506L
NO20062506L NO20062506A NO20062506A NO20062506L NO 20062506 L NO20062506 L NO 20062506L NO 20062506 A NO20062506 A NO 20062506A NO 20062506 A NO20062506 A NO 20062506A NO 20062506 L NO20062506 L NO 20062506L
Authority
NO
Norway
Prior art keywords
tissue
restoration
organs
enhancement
tissues
Prior art date
Application number
NO20062506A
Other languages
Norwegian (no)
Inventor
Michael Brines
Thomas Coleman
Anthony Cerami
Original Assignee
Kenneth S Warren Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kenneth S Warren Inst Inc filed Critical Kenneth S Warren Inst Inc
Publication of NO20062506L publication Critical patent/NO20062506L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Fremgangsmåter og anvendelser blir tilveiebrakt for en farmasøytisk sammensetning med et eryttopoetin eller et vevsbeskyttende cytokin for å beskytte eller å gjenopprette fiinksjon til en responsiv celle, vev, organ eller kroppsdelsfimksjon eller viabilitet i pattedyr når den gis utenfor det terapeutiske vinduet av tidligere godkjente terapeutika.Methods and applications are provided for a pharmaceutical composition with an erythopoietin or a tissue-protective cytokine to protect or restore function to a responsive cell, tissue, organ or body part function or mammal viability when administered outside the therapeutic window of prior approval.

NO20062506A 2004-05-20 2006-05-31 Tissue-protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues, and organs with an extended therapeutic window NO20062506L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/015863 WO2005117927A2 (en) 2004-05-20 2004-05-20 Tissue protective cytokines with an extended therapeutic window

Publications (1)

Publication Number Publication Date
NO20062506L true NO20062506L (en) 2006-05-31

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062506A NO20062506L (en) 2004-05-20 2006-05-31 Tissue-protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues, and organs with an extended therapeutic window

Country Status (7)

Country Link
CN (1) CN1897960A (en)
AU (1) AU2004319797A1 (en)
BR (1) BRPI0412869A (en)
IL (1) IL172036A0 (en)
IS (1) IS8222A (en)
NO (1) NO20062506L (en)
WO (1) WO2005117927A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (en) * 2017-10-10 2019-04-18 Augustinus Bader Erythropoietin (epo) application in spinal cord injury (sci) therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
WO2004087063A2 (en) * 2003-03-27 2004-10-14 Janssen Pharmaceutica Nv Use of erythropoietin in stroke recovery

Also Published As

Publication number Publication date
IS8222A (en) 2006-01-10
IL172036A0 (en) 2009-02-11
AU2004319797A8 (en) 2008-12-11
WO2005117927A2 (en) 2005-12-15
CN1897960A (en) 2007-01-17
BRPI0412869A (en) 2006-10-03
AU2004319797A1 (en) 2006-01-12
WO2005117927A3 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
NO20056000L (en) Tissue-protecting cytokines for the protection, reconstruction and enhancement of responsive cells, tissues and organs with an expanded therapeutic window
IS7619A (en) Tissue Protective Cells to Protect, Recover, and Improve Repressed Cells, Tissues and Organs
NO20050504L (en) Recombinant tissue-protective cytokines and nucleic acids encoding such, for the protection, reconstruction and enhancement of responsive cells, tissues and organs
NO20032912D0 (en) Protection, reconstruction and strengthening of erythropoietin responsive cells, tissues and organs
BRPI0818183A2 (en) Renal tissue repair and regeneration using cells derived from human umbilical cord tissue
BRPI0518281A2 (en) 11-beta hydroxylesterase dehydrogenase type i inhibitors and methods of using them
WO2003105757A3 (en) Methods and compositions for milieu-dependent binding of a targeted agent to a target
EP2298863A3 (en) Mesenchymal stem cells and uses therefor
WO2004101758A3 (en) Composition for maintaining organ and cell viability
SG146691A1 (en) Methods of preparing and using stem cell compositions and kits comprising the same
EP2548880A3 (en) Compositions for increasing telomerase activity
DE69030880D1 (en) Composition for stimulating the immune system
BR0210599A (en) Use of carbon monoxide, method for maintaining an animal cell in vitro, article of manufacture as well as sterile cell medium
DK0661987T3 (en) Morphogen-induced liver regeneration
NO20062506L (en) Tissue-protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues, and organs with an extended therapeutic window
CN116406288A8 (en) Methods for treating cancer or von-hippel-lindau disease using a combination of a PD-1 antagonist, a HIF-2 alpha inhibitor, and lenvatinib or a pharmaceutically acceptable salt thereof
WO2005084364A3 (en) Long acting tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
ATE396989T1 (en) DIBENZOøC CHROME-6-ONE DERIVATIVES AS AN AGAINST CANCER
ATE475099T1 (en) ASSESSMENT OF THE BIOLOGICAL ACTIVITY OF HGF (HEPATOCYTE GROWTH FACTOR)
DE60016567D1 (en) MACROPHAGE-BASED COMPOSITION WITH ANTI-INFECTIOUS AND HEMATOPOIETIC PROPERTIES AND THEIR METHOD OF PREPARATION
WO2004012677A3 (en) Methods and compositions to treat conditions associated with neovascularization
AR046572A1 (en) USE OF ENSO TRANSCRIPTION IMPROVERS IN CELLULAR THERAPY OF ISCHEMICAL HEART DISEASES
MD2671F1 (en) Antiviral and antiherpetic medicine in the form of gel
WO2023122721A3 (en) Peptides for cell-type specific targeting of the retina
Thawer et al. Effects of electrical stimulation on wound closure in mice with experimental diabetes mellitus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application